HSBC has upgraded Align Technology (ALGN) stock from “Hold” to “Buy,” increasing its price target to $200, a 33.33% raise. This upgrade, alongside other recent analyst revisions, reflects growing confidence in the company’s future performance. Align Technology, known for its Invisalign clear aligners, holds a dominant market share and continues to expand its patient base and product offerings like iTero intraoral scanners.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
ALGN Stock Upgraded by HSBC: Target Price Now $200 | ALGN Stock News
HSBC has upgraded Align Technology (ALGN) stock from “Hold” to “Buy,” increasing its price target to $200, a 33.33% raise. This upgrade, alongside other recent analyst revisions, reflects growing confidence in the company’s future performance. Align Technology, known for its Invisalign clear aligners, holds a dominant market share and continues to expand its patient base and product offerings like iTero intraoral scanners.